Roche

Pfizer’s latest copycat could put the squeeze on Roche — again
Endpoints
Fri, 01/26/18 - 10:57 am
Pfizer
Roche
biosimilars
Rituxan
PF-05280586
Roche doesn’t give up, plans recovery for Diabetes Care unit
GoinPharma
Sun, 01/21/18 - 09:03 pm
Roche
diabetes
Roche CEO Schwan concedes challenges as ‘highly, highly profitable’ drugs fall to biosimilar rivals
Fierce Pharma
Tue, 01/16/18 - 06:56 pm
Roche
Pharma CEOs
Severin Schwan
biosimilars
Herceptin
Rituxan
Avastin
Roche granted approval for ocrelizumab (multiple sclerosis) in Europe
GoinPharma
Sat, 01/13/18 - 10:48 pm
Roche
ocrelizumab
Europe
MS
multiple sclerosis
Roche snags another Perjeta combo nod, but will 'weak' data limit its use?
Fierce Pharma
Thu, 12/28/17 - 11:15 am
Roche
Perjeta
breast cancer
Oncology business to keep leading pharma market in 2018
GoinPharma
Wed, 12/27/17 - 09:39 am
oncology
Merck
Bristol-Myers Squibb
Pfizer
Roche
Roche’s and Bayer’s strategies compared
GoinPharma
Tue, 12/26/17 - 09:39 am
Roche
Bayer
3 Biotech Stocks That Soared This Week: Are They Buys?
Motley Fool
Sat, 12/23/17 - 11:39 pm
biotech
Ignyta
Roche
M&A
Molecular Templates
Biohaven Pharmaceuticals
trigriluzole
Roche Bets $1.7B More on Precision Oncology With Ignyta Deal
Xconomy
Fri, 12/22/17 - 09:51 am
Roche
Ignyta
M&A
precision medicine
oncology
Shire looks to stall Hemlibra impact with court injunction
BioPharma Dive
Tue, 12/19/17 - 12:03 pm
Shire
Hemlibra
Roche
hemophilia
Roche snaps up Huntington's drug on positive data
BioPharma Dive
Thu, 12/14/17 - 09:14 am
Roche
Huntington's disease
Ionis Pharmaceuticals
IONIS-HTTRx
ASH 2017: What you missed
BioPharma Dive
Wed, 12/13/17 - 06:35 pm
ASH17
Biomarin
Spark Therapeutics
Gilead Sciences
Novartis
Juno Therapeutics
AbbVie
Roche
JNJ
AbbVie Makes Progress on Quest to Diversify
Motley Fool
Tue, 12/12/17 - 10:40 pm
AbbVie
biosimilars
Roche
Venclexta
Phase 2 data for Roche’s lymphoma ADC doesn’t disappoint
Fierce Biotech
Tue, 12/12/17 - 10:10 am
Roche
ASH17
clinical trials
non-Hodgkin's lymphoma
antibody-drug conjugate
Roche's Fight With Pfizer May Be Just The Beginning
Forbes
Mon, 12/11/17 - 11:31 pm
Roche
Pfizer
Herceptin
biosimilars
cancer
Avastin
Rituxan
Roche study finds cancer 'Velcro' that halts T-cell attack
Reuters
Sun, 12/10/17 - 09:51 am
Roche
T-cells
cancer
drug development
Roche's latest Tecentriq results shed little light on the lung cancer market race: analyst
Fierce Pharma
Sat, 12/9/17 - 02:22 pm
Roche
Tecentriq
lung cancer
Roche, Novartis' Italian heads risk trial for alleged market rigging: sources
Yahoo/Reuters
Fri, 12/8/17 - 10:00 am
Roche
Novartis
Italy
Avastin
Lucentis
marketing manipulation
Roche's Tecentriq combo cuts risk of lung cancer progression
BioPharma Dive
Thu, 12/7/17 - 11:44 pm
Roche
Tecentriq
lung cancer
Most Impressive Drug Launch: Roche's Ocrevus
BioPharma Dive
Mon, 12/4/17 - 11:41 am
Roche
Ocrevus
drug launches
MS
multiple sclerosis

Pages